0102030405
CAS No 379270-37-8 TENOFOVIR ALAFENAMIDE Pharmaceutical Intermediates
02
introduction
Tenofovir alafenamide (TAF) is an important pharmaceutical compound widely used to treat HIV-1 infection and chronic hepatitis B virus (HBV) infection.
As a prodrug of tenofovir, TAF is designed to more effectively deliver the active drug to target cells, thereby reducing systemic exposure and reducing side effects.
Our tenofovir alafenamide is synthesized using advanced technology to ensure high purity and efficacy, making it an essential ingredient in the development of antiviral therapies.
As a prodrug of tenofovir, TAF is designed to more effectively deliver the active drug to target cells, thereby reducing systemic exposure and reducing side effects.
Our tenofovir alafenamide is synthesized using advanced technology to ensure high purity and efficacy, making it an essential ingredient in the development of antiviral therapies.
02
Physical and chemical properties
- Solubility: Soluble in water and organic solvents such as methanol and dimethyl sulfoxide (DMSO), making it easy to incorporate into various formulations.
- Boiling point: about 500°C, indicating stability under standard conditions.
- Melting Point: The melting point of this compound is around 150-155°C, making it easy to handle and store.
These properties make tenofovir alafenamide an ideal candidate for various pharmaceutical formulations, especially in the treatment of HIV and HBV infections.
- Boiling point: about 500°C, indicating stability under standard conditions.
- Melting Point: The melting point of this compound is around 150-155°C, making it easy to handle and store.
These properties make tenofovir alafenamide an ideal candidate for various pharmaceutical formulations, especially in the treatment of HIV and HBV infections.
1. Targeted Action: TAF is specifically designed to inhibit reverse transcriptase, effectively blocking viral replication with minimal side effects compared to older formulations.
2. Lower Dosage Requirements: Due to its improved pharmacokinetic profile, TAF requires a lower dose than its predecessor, tenofovir Alafenamide (TDF), thereby reducing toxicity and improving patient compliance.
3. Stability: The stability of the compound under various conditions ensures that it maintains its efficacy throughout the manufacturing process and shelf life.
4. Cost Effective: By sourcing directly from our integrated production facilities, customers can enjoy competitive pricing without compromising on quality.
5. Regulatory Compliance: Our manufacturing processes adhere to international quality standards, ensuring that our products meet the necessary regulatory requirements for pharmaceutical use.
2. Lower Dosage Requirements: Due to its improved pharmacokinetic profile, TAF requires a lower dose than its predecessor, tenofovir Alafenamide (TDF), thereby reducing toxicity and improving patient compliance.
3. Stability: The stability of the compound under various conditions ensures that it maintains its efficacy throughout the manufacturing process and shelf life.
4. Cost Effective: By sourcing directly from our integrated production facilities, customers can enjoy competitive pricing without compromising on quality.
5. Regulatory Compliance: Our manufacturing processes adhere to international quality standards, ensuring that our products meet the necessary regulatory requirements for pharmaceutical use.
Tenofovir alafenamide is mainly used in the pharmaceutical industry to treat HIV and HBV. Its applications include:
- Antiviral Drug Development: TAF is widely used as part of combination therapy for HIV-1 infection, improving the quality of life for many patients.
- Research and Development: Pharmaceutical researchers are conducting studies with tenofovir alafenamide aimed at understanding its pharmacology and exploring its potential in other viral infections.
- Quality Control: The high purity of Tenofovir Alafenamide ensures that the final product meets the strict quality standards required for pharmaceutical applications.
- Antiviral Drug Development: TAF is widely used as part of combination therapy for HIV-1 infection, improving the quality of life for many patients.
- Research and Development: Pharmaceutical researchers are conducting studies with tenofovir alafenamide aimed at understanding its pharmacology and exploring its potential in other viral infections.
- Quality Control: The high purity of Tenofovir Alafenamide ensures that the final product meets the strict quality standards required for pharmaceutical applications.
In conclusion, Tenofovir Alafenamide is an essential compound for the pharmaceutical industry, offering numerous advantages for the treatment of HIV and Hepatitis B.
As a manufacturing and trading company, we are proud to provide high-quality chemical products, including Tenofovir Alafenamide. Our commitment to quality, reliability, and customer satisfaction sets us apart in the industry.
We understand our customers' unique needs and strive to provide customized solutions to enhance their production processes. With our expertise and commitment to quality, we are a trusted partner for all your chemical needs.
Contact us today to learn more about our products and how we can support your business!
As a manufacturing and trading company, we are proud to provide high-quality chemical products, including Tenofovir Alafenamide. Our commitment to quality, reliability, and customer satisfaction sets us apart in the industry.
We understand our customers' unique needs and strive to provide customized solutions to enhance their production processes. With our expertise and commitment to quality, we are a trusted partner for all your chemical needs.
Contact us today to learn more about our products and how we can support your business!